Lunai Bioworks Inc. — Director's Dealing 2017

Jul 17, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2016-03-14

Reporting Person: Sindlev Rene (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3770869	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to purchase shares of common stock	$1.30	2022-04-21	Common Stock (5400000)		Indirect

Footnotes

F1: On February 11, 2014, RS Group ApS, an entity controlled by Mr. Sindlev, purchased 395,000 shares of the Issuer's common stock. On September 29, 2015, RS Group ApS purchased 120,000 shares of the Issuer's common stock. On March 14, 2016, RS Group ApS purchased 555,869 shares of the Issuer's common stock, after which Mr. Sindlev became the beneficial owner of greater than 10% of the Issuer's outstanding common stock. On April 21, 2017, RS Group ApS purchased 2,200,000 shares of the Issuer's common stock and 4,400,000 warrants to purchase shares of common stock and RS Arving ApS, an entity also controlled by Mr. Sindlev, purchased 500,000 shares of the Issuer's common stock and 1,000,000 warrants to purchase shares of common stock.